These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36797501)

  • 1. Characterization of the histological response to the Butterfly Prostatic Retraction Device in patients with benign prostatic hyperplasia.
    Katz R; Sze C; Punyala A; Ahmed MA; Safadi A; Roizman S; Zisman A; Aharoni S; Baniel J; Chughtai B
    World J Urol; 2023 Apr; 41(4):1141-1146. PubMed ID: 36797501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Butterfly: A Novel Minimally Invasive Transurethral Retraction Device for Benign Hypertrophy of the Prostate.
    Katz R; Ahmed MSA; Safadi A; Roizman S; Zisman A; Kabha M; Dekel Y; Baniel J; Aharony S
    Urol Int; 2023; 107(4):406-412. PubMed ID: 36720211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-in-man Safety and Efficacy of the ClearRing Implant for the Treatment of Benign Prostatic Hyperplasia.
    Vjaters E; Nitsan D; Mullerad M; Engelstein D; Leibovitch I; Feld Y
    Eur Urol Focus; 2020 Jan; 6(1):131-136. PubMed ID: 30293945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
    McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
    Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study.
    Sønksen J; Barber NJ; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Montorsi F; Patterson JM; Fahrenkrug L; Schoenthaler M; Gratzke C
    Eur Urol; 2015 Oct; 68(4):643-52. PubMed ID: 25937539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up.
    Porpiglia F; Fiori C; Amparore D; Kadner G; Manit A; Valerio M; Nicolaas L; Ho BSH; Alonso S; Schulman C; Barber N
    BJU Int; 2019 Jun; 123(6):1061-1069. PubMed ID: 30382600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostatic urethral lift: A novel minimally invasive treatment for benign prostatic hyperplasia].
    Liang JY; Lu YP
    Zhonghua Nan Ke Xue; 2016 Aug; 22(8):735-740. PubMed ID: 29019232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic Urethral Lift for Obstructive Median Lobes: Consistent Results Across Controlled Trial and Real-World Settings.
    Eure G; Rukstalis D; Roehrborn C
    J Endourol; 2023 Jan; 37(1):50-59. PubMed ID: 35876440
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.
    Porpiglia F; Fiori C; Bertolo R; Garrou D; Cattaneo G; Amparore D
    BJU Int; 2015 Aug; 116(2):278-87. PubMed ID: 25382816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.
    Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T
    Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years.
    Sievert KD; Schonthaler M; Berges R; Toomey P; Drager D; Herlemann A; Miller F; Wetterauer U; Volkmer B; Gratzke C; Amend B
    World J Urol; 2019 Jul; 37(7):1353-1360. PubMed ID: 30283994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
    Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
    Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of transurethral resection of prostate in clinical benign prostatic hyperplasia.
    Bozdar HR; Memon SR; Paryani JP
    J Ayub Med Coll Abbottabad; 2010; 22(4):194-6. PubMed ID: 22455296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EXPANDER-1 trial: introduction of the novel Urocross™ Expander System for treatment of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).
    Woo HH; Huang CP; Huang WJ; Chang YH; Lien CS; Chkhotua A; Elterman DS
    Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):576-582. PubMed ID: 35641601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between prostatic urethral angulation and symptomatic improvement after surgery in patients with lower urinary tract symptoms according to prostate size.
    Shim M; Bang WJ; Oh CY; Lee YS; Cho JS
    World J Urol; 2020 Aug; 38(8):1997-2003. PubMed ID: 31646381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar transurethral vaporization: a superior procedure in benign prostatic hyperplasia: a prospective randomized comparison with bipolar TURP.
    Falahatkar S; Mokhtari G; Moghaddam KG; Asadollahzade A; Farzan A; Shahab E; Ghasemi A; Allahkhah A; Esmaeili S
    Int Braz J Urol; 2014; 40(3):346-55. PubMed ID: 25010300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.